|
Date/Time |
Lecturer |
Affiliation |
Topic |
|
9/15/08
Monday
|
Ken Lloyd, PhD
Michael Palladino, PhD
|
Nereus |
NPI-0052 (proteasome inhibitor) and NPI-2358 (tumor vascular disrupting agent): Pre-Clinical Profile and Early Clinical Studies |
|
9/23/08 |
Stephen Howell, MD
Professor |
UCSD |
Introduction to Cancer Therapeutics Development |
|
9/30/08
|
Wolf Wrasidlo, PhD
Senior Project Scientist
|
UCSD |
Computer Aided Design of Small Molecule Inhibitors of Oncoproteins |
|
10/07/08 |
Nik Schork, PhD
Professor |
UCSD |
Cancer Driver and Passenger Mutations in Protein Kinases |
|
10/14/08 |
Maurizio Zanetti, MD
Professor |
UCSD |
Vaccination Against Cancer:
Trial, Errors and Moving the Science Forward |
|
10/21/08 |
Thomas Kipps, MD, PhD
Professor |
UCSD |
Active Immune Therapy of Human Leukemia: Mechanism of Cell
Clearance and Novel Targets for Immune Therapy
|
|
10/27/08
Monday
|
Aladar Sazlay, PhD
President & CEO |
Genelux Corporation |
Diagnosis and Therapy of Solid Human Tumors and Metastases in
Mouse Xenografts with Live Replicating Microorganisms
|
|
10/28/08 |
Tony Reid, MD, PhD
Associate Professor |
UCSD |
Early Phase Clinical Trials |
|
11/04/08 |
Karen Messer, PhD
Associate Professor |
UCSD |
Designs for Phase II Clinical Trials in Oncology |
|
11/13/08
Thursday |
Richard Kolodner, PhD
Executive Director of Laboratory Science and Technology |
Ludwig Institute for Cancer Research |
Use of Model Systems to Identify the Pathways that Prevent Genome Instability |
|
11/14/08
Friday |
Robert Hoffman
Director of Research |
Anticancer,
Inc. |
That Multiple Uses of Fluorescent Proteins to Visualize Cancer In Vivo |
|
11/18/08 |
Susan Taylor, PhD
Professor |
UCSD |
Protein Kinases: Dynamic Therapeutic Targets |
|
11/25/08 |
AJ Mundt, MD
Professor |
UCSD
|
Novel Radiation Oncology Technologies:
Development and Clinical Implementation |
|
12/02/08 |
Loki Natarajan, PhD
Professor
|
UCSD |
Principles of the Design of Phase III Clinical Trials |
|
12/09/08
|
Anne Wallace, MD
Professor |
UCSD |
Research Activities of the Breast Program |
|
12/15/08 |
Ajit Varki, MD
Professor |
UCSD |
Sialic Acid Changes in Cancer - Implications for Cancer Therapy |
1/09/09
Friday
|
Harvey R. Herschman, PhD |
UCLA Jonsson Comprehensive Cancer Center |
COX-2 and Cancer: Causes and Cures? |
2/10/09 |
Stephen Coutts, PhD, MBA |
Biocept, Inc. |
Use of Microfluidic Channels for Immunocapture of Circulating Tumor Cells |
3/17/09 |
Peter Schafer, PhD |
Celgene Corporation |
Immunomodulatory Activity of Lenalidomide: Implications for the Treatment of Hematological Malignancies |
4/16/09 |
Ingram Olkin, PhD
Professor of Statistics & Education |
Stanford University |
Meta-Analysis:
A History and Critique of Statistical Methods for Combining the Results of Independent Studies
|
4/30/09 |
David Weinriech |
Amgen |
Limitations and Improvements on P2 studies in Oncology |
5/19/09 |
Wayne Saville, PhD |
Biogen Idec |
Anti-CD20 Therapy – A Tale of Two Drugs
|
6/09/09 |
Michael Heller, PhD
Professor |
UCSD |
Challenges and Opportunities for New Molecular Diagnostics |
